NCT00315484View on ClinicalTrials.gov

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

PHASE4CompletedINTERVENTIONAL
Enrollment

358

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

October 31, 2004

Conditions
AnemiaChemotherapy
Interventions
DRUG

Epoetin alfa and Darbepoetin alfa

All Listed Sponsors
lead

Ortho Biotech Products, L.P.

INDUSTRY

NCT00315484 - Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia | Biotech Hunter | Biotech Hunter